# Target Weaning Oxygen to Determine Cafffeine Duration for AOP

> **NCT04868565** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of Chongqing Medical University** · enrollment: 310 (actual)

## Conditions studied

- Apnea of Prematurity
- Caffeine
- Weaning Oxygen
- Medicine Regimen

## Interventions

- **DRUG:** Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]

## Key facts

- **NCT ID:** NCT04868565
- **Lead sponsor:** Children's Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-10-15
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04868565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04868565, "Target Weaning Oxygen to Determine Cafffeine Duration for AOP". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04868565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*